|
Volume 272, Number 47, Issue of November 21, 1997
pp. 29426-29429
COMMUNICATION:
Phosphorylation of the N-Formyl Peptide Receptor Is
Required for Receptor Internalization but Not Chemotaxis*
(Received for publication, July 15, 1997, and in revised form, September 22, 1997)
Matthew H.
Hsu
,
Stephanie C.
Chiang
,
Richard D.
Ye
and
Eric R.
Prossnitz
From the Department of Immunology, The Scripps Research Institute,
La Jolla, California 92037
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES
ABSTRACT
The human N-formyl peptide receptor
(FPR) is a member of the family of leukocyte, G protein-coupled,
chemoattractant receptors. To determine the role(s) of receptor
phosphorylation in FPR processing and
formylmethionylleucylphenylalanine (fMLF)-mediated chemotaxis, we
utilized U937 cells expressing the recombinant wild type receptor and a
mutant form of the FPR. This mutant, which lacks all of the serine and
threonine residues in the C terminus of the receptor, ST, has
recently been shown to produce a receptor capable of fMLF binding and G
protein activation but was demonstrated not to undergo
fMLF-dependent phosphorylation or desensitization of the
calcium mobilization response upon repeated exposure to agonist (Prossnitz, E. R. (1997) J. Biol. Chem. 272, 15213-15219). In this report, we examined the role of receptor
phosphorylation in FPR internalization and leukocyte chemotaxis.
Whereas the wild type receptor was rapidly internalized upon
stimulation, the phosphorylation-deficient mutant was not, remaining
entirely on the cell surface. In addition, contrary to the hypothesis
that receptor processing and recycling are required for chemotaxis, we
found no defect in the ability of the mutant FPR to migrate up a
concentration gradient of fMLF. These results indicate that
phosphorylation of the FPR is a necessary step in receptor
internalization but that receptor phosphorylation, desensitization, and
internalization are not required for chemotaxis.
INTRODUCTION
Neutrophils normally exist in a resting state as they circulate
though the body. However, upon interaction with small molecules known
as chemoattractants, they rapidly respond with endothelial adhesion
followed by emigration from the vasculature and chemotaxis to the site
of inflammation (1). Chemoattractants activate neutrophils through
binding to heptahelical receptors located on the cell surface (2, 3).
These receptors activate heterotrimeric GTP-binding proteins (G
proteins)1 that initiate
numerous elaborate signal transduction cascades, culminating in
neutrophil migration and activation. Once at the site of inflammation,
neutrophils respond with phagocytosis, superoxide generation, and the
release of degradative enzymes (4). One of the most thoroughly studied
chemoattractant receptors is the N-formyl peptide receptor
(FPR), which recognizes short N-formylated oligopeptides of
bacterial or mitochondrial origin (5-7).
Leukocyte chemotaxis has been shown to be dependent on the binding of
chemoattractants to their respective receptors (8, 9). Following
binding of the ligand and cellular activation, the receptors undergo
desensitization and internalization (10, 11). Once internalized, ligand
dissociates from the receptor and is degraded, whereupon the receptor
is recycled to the cell surface for additional rounds of activation
(10). Receptor recycling has been suggested to be essential for
sustained cellular responses, such as cell chemotaxis (12, 13).
Inhibition of receptor recycling through exposure to wheat germ
agglutinin or by neuraminidase treatment was found to block chemotaxis
without affecting receptor-mediated superoxide generation or
degranulation. Receptor endocytosis was also demonstrated to proceed
normally with the internalized receptor accumulating within the cell
and not being re-expressed to the cell surface (12, 13). A role for
neutral endopeptidase has also been implicated through the use of the
inhibitor phosphoramidon (14). Treatment with this inhibitor blocked
degradation of the internalized ligand as well as re-expression of the
internalized receptor, suggesting that dissociation of the ligand from
the receptor and its subsequent hydrolysis are essential for receptor recycling (15). In fact, degradation of internalized ligand was shown
to occur at a rate proportional to receptor re-expression, suggesting
that the former process may be rate-limiting. Inhibition of receptor
recycling through this method specifically blocked chemotaxis but not
other neutrophil responses, providing further support for the
conclusion that receptor recycling is required for chemotaxis (15).
We have recently shown that phosphorylation of the FPR is an essential
step in the functional desensitization of the receptor. In this report,
we investigated the role of receptor phosphorylation in the
internalization process as a means to examine the role of receptor
processing in chemotaxis. Our results demonstrate that although
receptor phosphorylation is absolutely essential to receptor
desensitization and internalization, neither phosphorylation nor
receptor internalization is required for cell chemotaxis.
EXPERIMENTAL PROCEDURES
Materials
The cDNA encoding the FPR was obtained from a
human HL-60 granulocyte library as described previously (16).
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein and indo-1AM
were obtained from Molecular Probes. fMLF was purchased from Sigma.
Carrier-free, acid-free [32P]orthophosphate was from
Amersham Corp. Protein A-Sepharose CL-4B beads were obtained from
Pharmacia Biotech Inc. Chemotaxis chambers (48-well) were from
Neuroprobe with cellulose nitrate filters from Toyo. RPMI was from
Whittaker Bioproducts; fetal bovine serum was from HyClone.
Construction and Expression of Site-directed Mutants in U937
Cells
The FPR cDNA was subcloned and mutagenized as described
(16, 17). U937 cells were grown in RPMI 1640 supplemented with 2 mM L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, 10 mM HEPES (pH 7.4), and 10%
heat-inactivated fetal bovine serum. For transfection, approximately
4 × 106 cells were harvested and resuspended in 400 µl of RPMI 1640 containing 10 mM glucose and 0.1 mM dithiothreitol (18). Linearized DNA (10 µg in a volume
of 10 µl) was added to the cells and preincubated for 5 min at room
temperature. The cells were then subjected to a 240-V pulse from a
960-microfarad capacitor (resulting in a pulse time constant of
approximately 30 ms) and immediately returned to 5-10 ml of culture
medium. The following day, G418 was added to a final active
concentration of 1 mg/ml. As the selection proceeded, the cells were
centrifuged and resuspended in fresh medium (containing G418) at
4-6-day intervals. Cells were cultured at 37 °C in a humidified
atmosphere of 6% CO2 and 94% air.
In Vivo Phosphorylation and
Immunoprecipitation
Phosphorylation of the FPR was determined as
described (19). Briefly, FPR-transfected U937 cells were harvested and
washed extensively to remove traces of phosphate. Cells were
resuspended in phosphate-free RPMI 1640 containing 1 mCi of
carrier-free, acid-free [32P]orthophosphate (10 mCi/ml).
Cells were loaded for 3 h at 37 °C and subsequently stimulated
with fMLF for 10 min at 37 °C. Cells were lysed by the addition of
0.33 volume of 4 × radioimmune precipitation buffer (40 mM Tris-HCl, pH 7.5, 600 mM NaCl, 4 mM EDTA, 0.4% SDS, 2% deoxycholate, 4% Triton X-100, 4 mM p-nitrophenyl phosphate, 40 mM
sodium phosphate, 40 mM NaF, 20 µg/ml soybean trypsin
inhibitor, 20 µg/ml leupeptin, 2 mM phenylmethylsulfonyl
fluoride, 400 ng/ml aprotinin, and 200 µg/ml pepstatin A). Following
lysis, extraction, and removal of insoluble debris, the supernatant was
added to 10 mg of Protein A-Sepharose, which had been precoated with 15 µl of a rabbit antiserum directed against the C-terminal 12 amino acids of the FPR, and incubated for 1 h while rotating at 4 °C. The beads were then washed as follows: once with 1 ml of 50 mM Tris-HCl, 500 mM NaCl, 1% Triton X-100,
0.2% SDS, pH 8.0; once with 1 ml of 50 mM Tris-HCl, 500 mM NaCl, 1% Triton X-100, 0.1% SDS, pH 8.0; once with 1 ml of 50 mM Tris-HCl, 500 mM NaCl, pH 8.0; and
finally with phosphate-buffered saline. Laemmli sample buffer was
added, and the samples were heated at 37 °C for 10 min, followed by
electrophoresis on a 12.5% SDS-polyacrylamide gel. Gels were dried,
and 32P content was determined with a Molecular Dynamics
PhosphorImager.
Desensitization
To assess desensitization, the ability of
the cells to respond to ligand with a calcium mobilization response was
monitored. For calcium determinations, cells were harvested by
centrifugation, washed once with phosphate-buffered saline, and
resuspended at 5 × 106 cells/ml in Hanks' buffered
saline solution (HBSS). The cells were incubated with 5 µM indo-1AM for 25 min at 37 °C, washed once with
HBSS, and resuspended to a concentration of approximately 106 cells/ml in HBSS containing 1.5 mM EGTA, pH
8.0. The elevation of intracellular Ca2+ by fMLF was
monitored by continuous fluorescence measurement using an SLM 8000 photon-counting spectrofluorometer (SLM-Aminco) detecting at 400 and
490 nm, respectively, as described (16). The concentration of
intracellular Ca2+ was calculated as described (20). For
desensitization determinations, cells were first pretreated with 1 µM fMLF, and the response was recorded. The stimulated
cells were then removed from the cuvette, washed three times with HBSS
at room temperature to remove surface-bound fMLF, and replaced in the
cuvette. The response of the washed cells to a second stimulation with
1 µM fMLF was then determined.
Receptor Internalization
Receptor internalization was first
determined as the loss of FPR from the cell surface as follows.
FPR-transfected U937 cells were harvested, washed, and resuspended in
HBSS. Cells were then stimulated with 1 µM fMLF for 10 min at 37 °C and washed three times with HBSS. Remaining cell
surface receptors were determined with 10 nM
N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein. Following incubation for at least 15 min on ice, cells were analyzed for fluorescent intensity on a FACScan flow cytometer (Becton Dickinson) with dead cells excluded by a gate on forward and side scatter. Nonspecific binding was determined in the presence of 1 µM N-formyl-Met-Leu-Phe. Receptor
internalization was determined relative to cells that had not been
treated with fMLF.
Internalization was also evaluated as the intracellular accumulation of
fML[3H]F as follows. FPR-transfected U937 cells were
harvested, washed, and resuspended in HBSS. Cells were incubated with
the indicated concentration of fML[3H]F at 37 °C for
60 min. Control cells were incubated on ice (which prevents
endocytosis) or with excess unlabeled fMLF to determine nonspecific
binding and internalization. After incubation, cell samples were added
to 10 volumes of 0.2 M glycine (pH 3.0) containing 0.5 M NaCl for 5 min on ice. This incubation removes ligand
bound to the cell surface but has no effect on internalized ligand. Cell samples added to 10 volumes of cold Hanks' buffer (as opposed to
pH 3.0 glycine) provided total fML[3H]F associated with
the cell, both internal and external. Free ligand was separated from
cell-associated ligand by rapid filtration through glass fiber filters
followed by three washes with cold dilution buffer. Results are
expressed as the percentage of saturably bound fML[3H]F
that is internalized and normalized to the amount internalized by the
wild type FPR.
Chemotaxis
Cell migration was quantitated with a 48-well
chemotaxis chamber (Neuroprobe) using 5.0- or 8.0-µm pore size
cellulose nitrate filters (9). Cells and fMLF were prepared in HBSS
supplemented with 10 mM HEPES and 1% bovine serum albumin.
Chemoattractant was placed in the lower chamber and covered with the
cellulose nitrate filter. Cells (4 × 106/ml) were
placed in the upper chamber and incubated at 37 °C for 2 h.
Following the incubation, the filter was fixed with isopropyl alcohol,
stained with hematoxylin, and mounted on a microscope slide. The
distance migrated by the cells (in µm) was determined by the leading
edge technique (21). For each evaluation, five fields per duplicate
filter were measured at 400-fold magnification. The data are presented
as the distance migrated by the leading front of the cells in a 2-h
span.
RESULTS AND DISCUSSION
It has been well established that G protein-coupled
chemoattractant receptors mediate leukocyte chemotaxis (22). The signal transduction cascade initiated by these receptors has also been shown
to be essential since treatment of cells with pertussis toxin, which
blocks the interaction of Gi proteins with receptors, completely abolishes leukocyte chemotaxis (23-25). Furthermore, actin
polymerization has been demonstrated to be essential, since cytochalasins, which block actin polymerization, also abolish chemotaxis (26, 27). Much of the signaling between these two events,
however, remains unclear. We have sought to determine the role of
receptor processing in these events. Previous experiments have
suggested that recycling of chemoattractant receptors is essential for
chemotaxis to take place. This conclusion was based on a number of
experiments, which correlated a block in the re-expression of
internalized chemoattractant receptors with a lack of chemotactic ability despite normal ligand binding, cell activation of
superoxide generation and degranulation, and normal receptor
internalization (15, 28).
In this study, we have used a unique approach to investigate the role
of receptor processing in chemotaxis. We have previously demonstrated
that U937 myeloid cells stably transfected with chemoattractant receptors such as the FPR are capable of migrating up a chemotactic gradient (9). This chemotactic response is indistinguishable from the
response observed with differentiated U937 cells or neutrophils. To
evaluate the role of receptor processing, we compared U937 cells
transfected with the wild type FPR to U937 cells transfected with a
mutant form of the FPR, ST, in which all of the serine and threonine
residues in the C terminus have been converted to alanines and
glycines. Fig. 1 demonstrates that,
whereas the wild type FPR becomes phosphorylated upon stimulation with
fMLF, the ST mutant does not. That the mutant form of the FPR was
capable of responding to fMLF was demonstrated by monitoring the
mobilization of intracellular calcium. Upon fMLF stimulation, both the
wild type and ST mutant underwent similar degrees of calcium
mobilization (Fig. 2). This indicated
that in the absence of receptor phosphorylation, ligand binding and G
protein activation remained intact. We examined desensitization of the
fMLF-initiated calcium mobilization response by taking cells that had
been exposed to a saturating concentration of fMLF yielding a maximal
calcium mobilization response, washing them extensively to remove bound
ligand, and determining their responsiveness to a second exposure to
fMLF. As expected for the wild type FPR, the amount of calcium
mobilization following a second exposure to agonist was minimal (Fig.
2). However, exposing fMLF-treated ST cells to a second dose of
ligand yielded a calcium response of the same magnitude as that
observed for the first exposure. These results confirm that receptor
phosphorylation is an essential step in the functional desensitization
of the receptor-mediated response.
Fig. 1.
Phosphorylation of the wild type FPR and
ST mutant in transfected U937 cells. Cells were loaded with
[32P]orthophosphate and treated with 1 µM
fMLF for 10 min prior to solubilization and immunoprecipitation of the
FPR. Lane 1, vector-transfected U937 cells; lane
2, wild type FPR-transfected U937 cells; lane 3, mutant
ST-transfected U937 cells. Data shown are representative of four
experiments.
[View Larger Version of this Image (59K GIF file)]
Fig. 2.
Desensitization of calcium mobilization of
the wild type FPR and ST mutant. FPR desensitization was
determined as the decrease in fMLF-stimulated elevation of
intracellular calcium in response to a second exposure to fMLF. Cells
expressing the wild type (WT) and ST mutant form of the
FPR were loaded with indo-1AM and stimulated (pretreated) with 1 µM fMLF. The cells were then washed extensively to remove
bound ligand and re-assessed for calcium mobilization in response to a
second stimulation with 1 µM fMLF. Data represent
mean ± S.E. of four experiments.
[View Larger Version of this Image (15K GIF file)]
To determine what mechanism may underlie this phenomenon, we next
evaluated the ability of the receptor to undergo ligand-stimulated internalization. Receptor internalization provides possible mechanisms for desensitization by removing occupied receptors from the cell surface to intracellular endosomes. We initially evaluated receptor endocytosis by determining the amount of receptor remaining on the cell
surface following a period of exposure to fMLF. Cell surface receptors
were quantitated by flow cytometry using
N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein as a specific
probe for cell surface-localized FPR. When U937 cells transfected with
the wild type FPR were exposed to fMLF for 10 min at 37 °C and
assayed for cell surface receptors, they exhibited a 75% decrease in
the number of cell surface receptors compared with cells that had not
been exposed to fMLF (Fig.
3A). However, when the same
comparison was made with U937 cells expressing the ST FPR mutant,
which express almost equal numbers of receptors, there was no decrease
in the number of cell surface receptors following a pretreatment with
fMLF. To confirm that the decrease in cell surface receptors was the
result of ligand-mediated receptor internalization, we also measured
uptake of tritiated ligand. Increasing concentrations of
fML[3H]F were incubated with wild type and mutant cells
for 1 h at 37 °C. The cells were then transferred to a low pH
buffer, which causes dissociation of ligand bound to the cell surface
but has no effect on internalized ligand. Wild type FPR-transfected
U937 cells demonstrated significant uptake of fML[3H]F
during the course of the assay (Fig. 3B). On the contrary, cells expressing the ST mutant internalized almost no ligand, even
at fMLF concentrations 10-fold higher than that required to demonstrate
significant uptake with the wild type receptor. These results suggest
that receptor phosphorylation is required for internalization as well
as desensitization of the FPR and that the two processes may be
interdependent.
Fig. 3.
Internalization of the wild type FPR is
dependent upon receptor phosphorylation. A, cell surface
expression of the wild type (WT) and
phosphorylation-deficient mutant ( ST) of the FPR. Cells
were pretreated with 1 µM fMLF (+) or buffer only ( ) for 10 min at 37 °C, washed extensively, and incubated with 10 nM N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein
prior to analysis by flow cytometry. Mean fluorescent intensity was
taken to represent relative cell surface receptor expression. For both
wild type and ST cells, receptor expression is expressed relative to
the receptor present in untreated cells. B, internalization
of the wild type receptor (open circles) and ST mutant
FPR (solid circles) was also determined by the uptake of
fML[3H]F using a filtration-based method. Following
incubation in the indicated concentration of fML[3H]F,
remaining surface-bound ligand was removed by a low pH wash so that
only internalized ligand was retained on the filter. Data are
representative of four experiments.
[View Larger Version of this Image (17K GIF file)]
Having defined a form of the FPR that is capable of binding ligand and
initiating signal transduction but incapable of being internalized and
thus recycled to the cell surface, we were now able to test the
hypothesis that chemotaxis requires recycling of the receptor.
Chemotaxis was evaluated using a 48-well chemotaxis chamber with the
lower chamber containing chemoattractant separated from the upper
chamber containing cells by a 120-µm thick convoluted pore cellulose
nitrate filter. This method allows the distinction to be made between
simple migration though an "open hole" thin polycarbonate filter
and true chemotaxis as revealed with this method. Only myeloid cells
are capable of migrating through thick convoluted pore filters whereas
many cell types including endothelial cells and fibroblasts, for
example, can traverse straight open hole pore filters. The ability of
the FPR-transfected U937 cells to undergo chemotaxis in response to a
gradient is demonstrated in Table I. Only
in the presence of a ligand gradient, with the higher concentration of
ligand in the lower chamber, was significant migration into the filter
observed. The pattern of migration is consistent with the cells
responding in a chemotactic manner, as opposed to a chemokinetic
manner, where the presence of ligand in the upper chamber (or both
chambers) induces increased random movement of the cells and therefore
migration into the filter. Chemotaxis of undifferentiated U937 cells is
dependent only upon the introduction of a chemoattractant receptor,
such as the FPR, with vector-transfected cells showing no response
(Fig. 4). When we tested the ST FPR
mutant, we found that the chemotactic potential of this mutant was
identical to that of the wild type receptor, demonstrating that
receptor processing and recycling are not required for chemotaxis to
take place.
Table I.
Checkerboard analysis of FPR-transfected U937 cell chemotactic
activity
Data are expressed as the distance of migration (in microns) in a 2-h
period as described under "Experimental Procedures." Values are
means of five measurements on each of duplicate filters and are
representative of three experiments.
|
| fMLF in lower chamber |
fMLF
in upper chamber
|
| 0 |
1 nM |
10 nM |
100
nM |
|
| 0 |
0 |
0 |
0 |
0 |
| 1
nM |
12 |
0 |
10 |
0 |
| 10
nM |
46 |
32 |
11 |
10 |
| 100
nM |
53 |
39 |
22 |
0 |
|
Fig. 4.
Chemotaxis mediated by the wild type FPR is
independent of receptor phosphorylation. Receptor-mediated
chemotaxis was evaluated using a 48-microwell chemotaxis chamber. Cell
migration (in µm) was determined as a function of the concentration
of fMLF in the lower chamber after an incubation period of 2 h at
37 °C. , wild type FPR-transfected U937 cells; , ST mutant
FPR-transfected U937 cells; , vector only-transfected U937 cells.
Data are means of duplicate assays, representative of four
experiments.
[View Larger Version of this Image (20K GIF file)]
The results of this study have demonstrated for the first time that
receptor phosphorylation, internalization, desensitization, and
recycling are not required for chemotaxis to occur. Our result is
contrary to the conclusions based on inhibitors of receptor recycling,
which result in inhibition of neutrophil chemotaxis. It is unclear,
however, what additional side effects these inhibitors might have upon
cell function. Furthermore, it is possible that only in the presence of
internalized receptor is receptor re-expression required for chemotaxis
to occur. This would indicate that under normal circumstances,
replenishing of cell surface receptors is essential to provide the
receptors necessary to propagate migration; however, as our
results demonstrate, in the absence of receptor depletion through
internalization, chemotaxis can be initiated and continue for a
prolonged period of time. This demonstrates that signal
transduction mediated by a functional chemoattractant receptor in
the absence of receptor desensitization can control the spatial and
temporal aspects of the signal transduction cascade that are involved
in the remodeling of the actin cytoskeleton that propels the cell
forward during chemotaxis. Although receptor desensitization and
internalization are not required for chemotaxis, these processes are
involved in preventing chronic activation of leukocytes at sites of
inflammation. To compensate for the possible lack of receptors during
the relatively long periods of chemotaxis, it appears that
re-expression of internalized receptors has evolved as a mechanism to
ensure sufficient cell surface receptors. In conclusion, although
receptor recycling occurs during chemotaxis, it is not an essential
component of the chemotactic phenomenon.
FOOTNOTES
*
This research was supported by National Institutes of Health
Grants AI36357 (to E. R. P.) and AI33503 (to R. D. Y.) and by a
grant-in-aid from the American Heart Association (to E. R. P.). This
is Publication 10987-IMM from the Department of Immunology, the Scripps
Research Institute.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed:
Dept. of Immunology, IMM25, The Scripps Research Inst., 10550 N. Torrey
Pines Rd., La Jolla CA 92037. Tel.: 619-784-8549; Fax: 619-784-8476;
E-mail: epross{at}scripps.edu.
1
The abbreviations used are: G protein, guanine
nucleotide-binding regulatory protein; FPR, N-formyl peptide
receptor; Nle, norleucine; fMLF,
N-formyl-methionyl-leucyl-phenylalanine; HBSS, Hanks'
buffered saline solution.
ACKNOWLEDGEMENT
We thank Dr. Richard Kew for expertise in
analyzing chemotaxis results.
REFERENCES
-
Zigmond, S. H.
(1989)
Curr. Opin. Cell Biol.
1,
80-86
[CrossRef][Medline]
[Order article via Infotrieve]
-
Murphy, P. M.
(1994)
Annu. Rev. Immunol.
12,
593-633
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ye, R. D., and Boulay, F.
(1997)
Adv. Pharmacol.
39,
221-289
-
Snyderman, R., and Uhing, R. J.
(1992)
in
Inflammation: Basic Principles and Clinical Correlates (Gallin, J. I., Goldstein, I. M., and Snyderman, R., eds), 2nd Ed., pp. 421-439, Raven Press, New York
-
Boulay, F., Tardif, M., Brouchon, L., and Vignais, P.
(1990)
Biochem. Biophys. Res. Commun.
168,
1103-1109
[CrossRef][Medline]
[Order article via Infotrieve]
-
Prossnitz, E. R., and Ye, R. D.
(1997)
Pharmacol. Ther.
74,
73-102
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schiffmann, E., Showell, H. V., Corcoran, B. A., Ward, P. A., Smith, E., and Becker, E. L.
(1975)
J. Immunol.
114,
1831-1837
[Abstract/Free Full Text]
-
Zigmond, S. H.
(1989)
Am. J. Respir. Cell Mol. Biol.
1,
451-453
-
Kew, R. R., Peng, T., DiMartino, S. J., Madhavan, D., Weinman, S. J., Cheng, D., and Prossnitz, E. R.
(1997)
J. Leukocyte Biol.
61,
329-337
[Abstract]
-
van Epps, D. E., Simpson, S., Bender, J. G., and Chenoweth, D. E.
(1990)
J. Immunol.
144,
1062-1068
[Abstract]
-
Wilde, M. W., Carlson, K. E., Manning, D. R., and Zigmond, S. H.
(1989)
J. Biol. Chem.
264,
190-196
[Abstract/Free Full Text]
-
Perez, H. D., Elfman, F., Marder, S., Lobo, E., and Ives, H. E.
(1989)
J. Clin. Invest.
83,
1963-1970
-
Perez, H. D., Ong, R., Khanna, K., Banda, D., and Goldstein, I. M.
(1982)
J. Immunol.
129,
2718-2724
[Abstract]
-
Painter, R. G., Dukes, R., Sullivan, J., Carter, R., Erdos, E. G., and Johnson, A. R.
(1988)
J. Biol. Chem.
263,
9456-9461
[Abstract/Free Full Text]
-
Painter, R. G., and Aiken, M. L.
(1995)
J. Leukocyte Biol.
58,
468-476
[Abstract]
-
Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., and Ye, R. D.
(1991)
Biochem. Biophys. Res. Commun.
179,
471-476
[CrossRef][Medline]
[Order article via Infotrieve]
-
Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., and Ye, R. D.
(1993)
Biochem. J.
294,
581-587
-
Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., and Ye, R. D.
(1993)
J. Immunol.
151,
5704-5715
[Abstract]
-
Prossnitz, E. R.
(1997)
J. Biol. Chem.
272,
15213-15219
[Abstract/Free Full Text]
-
Cobbold, P. H., and Rink, T. J.
(1987)
Biochem. J.
248,
313-328
[Medline]
[Order article via Infotrieve]
-
Zigmond, S. H., and Hirsch, J. G.
(1973)
J. Exp. Med.
137,
387-410
[Abstract]
-
Snyderman, R., Smith, C. D., and Verghese, M. W.
(1986)
J. Leukocyte Biol.
40,
785-800
[Abstract]
-
Lad, P. M., Olson, C. V., and Grewal, I. S.
(1986)
FEBS Lett.
200,
91-96
[CrossRef][Medline]
[Order article via Infotrieve]
-
Becker, E. L., Kermode, J. C., Naccache, P. H., Yassin, R., Marsh, M. L., Munoz, J. J., and Sha'afi, R. I.
(1985)
J. Cell Biol.
100,
1641-1646
[Abstract/Free Full Text]
-
Spangrude, G. J., Sacchi, F., Hill, H. R., Van Epps, D. E., and Daynes, R. A.
(1985)
J. Immunol.
135,
4135-4143
[Abstract]
-
Pham Huu, T.
(1979)
Biomedicine (Paris)
30,
121-124
-
Becker, E. L., Davis, A. T., Estensen, R. D., and Quie, P. G.
(1972)
J. Immunol.
108,
396-402
[Abstract/Free Full Text]
-
Perez, H. D., Elfman, F., Lobo, E., Sklar, L., Chenoweth, D., and Hooper, C.
(1986)
J. Immunol.
136,
1803-1812
[Abstract]
Volume 272, Number 47,
Issue of November 21, 1997
pp. 29426-29429
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev.,
June 1, 2009;
61(2):
119 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chigaev, A. Waller, O. Amit, L. Halip, C. G. Bologa, and L. A. Sklar
Real-time Analysis of Conformation-sensitive Antibody Binding Provides New Insights into Integrin Conformational Regulation
J. Biol. Chem.,
May 22, 2009;
284(21):
14337 - 14346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Byers, P. A. Calloway, L. Shannon, H. D. Cunningham, S. Smith, F. Li, B. C. Fassold, and C. M. Vines
Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL21
J. Immunol.,
October 1, 2008;
181(7):
4723 - 4732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Babbin, A. J. Jesaitis, A. I. Ivanov, D. Kelly, M. Laukoetter, P. Nava, C. A. Parkos, and A. Nusrat
Formyl Peptide Receptor-1 Activation Enhances Intestinal Epithelial Cell Restitution through Phosphatidylinositol 3-Kinase-Dependent Activation of Rac1 and Cdc42
J. Immunol.,
December 15, 2007;
179(12):
8112 - 8121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chigaev, A. Waller, G. J. Zwartz, T. Buranda, and L. A. Sklar
Regulation of Cell Adhesion by Affinity and Conformational Unbending of {alpha}4beta1 Integrin
J. Immunol.,
June 1, 2007;
178(11):
6828 - 6839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xue, G. Hsieh, M. A. Raymond-Stintz, J. Pfeiffer, D. Roberts, S. L. Steinberg, J. M. Oliver, E. R. Prossnitz, D. S. Lidke, and B. S. Wilson
Activated N-Formyl Peptide Receptor and High-Affinity IgE Receptor Occupy Common Domains for Signaling and Internalization
Mol. Biol. Cell,
April 1, 2007;
18(4):
1410 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sai, G. Walker, J. Wikswo, and A. Richmond
The IL Sequence in the LLKIL Motif in CXCR2 Is Required for Full Ligand-induced Activation of Erk, Akt, and Chemotaxis in HL60 Cells
J. Biol. Chem.,
November 24, 2006;
281(47):
35931 - 35941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Balabanian, B. Lagane, J. L. Pablos, L. Laurent, T. Planchenault, O. Verola, C. Lebbe, D. Kerob, A. Dupuy, O. Hermine, et al.
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
Blood,
March 15, 2005;
105(6):
2449 - 2457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sai, G.-H. Fan, D. Wang, and A. Richmond
The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis
J. Cell Sci.,
November 1, 2004;
117(23):
5489 - 5496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xue, C. M. Vines, T. Buranda, D. F. Cimino, T. A. Bennett, and E. R. Prossnitz
N-Formyl Peptide Receptors Cluster in an Active Raft-associated State Prior to Phosphorylation
J. Biol. Chem.,
October 22, 2004;
279(43):
45175 - 45184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chigaev, G. J. Zwartz, T. Buranda, B. S. Edwards, E. R. Prossnitz, and L. A. Sklar
Conformational Regulation of {alpha}4{beta}1-Integrin Affinity by Reducing Agents: "INSIDE-OUT" SIGNALING IS INDEPENDENT OF AND ADDITIVE TO REDUCTION-REGULATED INTEGRIN ACTIVATION
J. Biol. Chem.,
July 30, 2004;
279(31):
32435 - 32443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Revankar, C. M. Vines, D. F. Cimino, and E. R. Prossnitz
Arrestins Block G Protein-coupled Receptor-mediated Apoptosis
J. Biol. Chem.,
June 4, 2004;
279(23):
24578 - 24584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kavelaars, A. Vroon, R. P. Raatgever, A. M. Fong, R. T. Premont, D. D. Patel, R. J. Lefkowitz, and C. J. Heijnen
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
J. Immunol.,
December 1, 2003;
171(11):
6128 - 6134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Richardson, R. J. Marjoram, L. S. Barak, and R. Snyderman
Role of the Cytoplasmic Tails of CXCR1 and CXCR2 in Mediating Leukocyte Migration, Activation, and Regulation
J. Immunol.,
March 15, 2003;
170(6):
2904 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. He, D. D. Browning, and R. D. Ye
Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling
J. Immunol.,
March 15, 2001;
166(6):
4099 - 4105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Miettinen, J. Gripentrog, and A. Jesaitis
Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin
J. Cell Sci.,
June 8, 2000;
111(14):
1921 - 1928.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Christophe, M.-J. Rabiet, M. Tardif, M.-D. Milcent, and F. Boulay
Human Complement 5a (C5a) Anaphylatoxin Receptor (CD88) Phosphorylation Sites and Their Specific Role in Receptor Phosphorylation and Attenuation of G Protein-mediated Responses. DESENSITIZATION OF C5a RECEPTOR CONTROLS SUPEROXIDE PRODUCTION BUT NOT RECEPTOR SEQUESTRATION IN HL-60 CELLS
J. Biol. Chem.,
January 21, 2000;
275(3):
1656 - 1664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin, A. Van Linden, and D. W. H. Riches
Phosphorylation of Tumor Necrosis Factor Receptor CD120a (p55) by p42mapk/erk2 Induces Changes in Its Subcellular Localization
J. Biol. Chem.,
November 12, 1999;
274(46):
32975 - 32987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Maestes, R. M. Potter, and E. R. Prossnitz
Differential Phosphorylation Paradigms Dictate Desensitization and Internalization of the N-Formyl Peptide Receptor
J. Biol. Chem.,
October 15, 1999;
274(42):
29791 - 29795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Sambrano and S. R. Coughlin
The Carboxyl Tail of Protease-activated Receptor-1 Is Required for Chemotaxis. CORRELATION OF SIGNAL TERMINATION AND DIRECTIONAL MIGRATION
J. Biol. Chem.,
July 16, 1999;
274(29):
20178 - 20184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bunemann and M M. Hosey
G-protein coupled receptor kinases as modulators of G-protein signalling
J. Physiol.,
May 15, 1999;
517(1):
5 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Malecz, T. Bambino, M. Bencsik, and R. A. Nissenson
Identification of Phosphorylation Sites in the G Protein-Coupled Receptor for Parathyroid Hormone. Receptor Phosphorylation Is Not Required for Agonist-Induced Internalization
Mol. Endocrinol.,
December 1, 1998;
12(12):
1846 - 1856.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. G. Thomas, T. J. Motel, C. E. Kule, V. Karoor, and K. M. Baker
Phosphorylation of the Angiotensin II (AT1A) Receptor Carboxyl Terminus: A Role in Receptor Endocytosis
Mol. Endocrinol.,
October 1, 1998;
12(10):
1513 - 1524.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. A. Bennett, D. C. Maestas, and E. R. Prossnitz
Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved "DRY" Sequence
J. Biol. Chem.,
August 4, 2000;
275(32):
24590 - 24594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2
J. Biol. Chem.,
June 8, 2001;
276(24):
21585 - 21593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kraft, H. Olbrich, I. Majoul, M. Mack, A. Proudfoot, and M. Oppermann
Characterization of Sequence Determinants within the Carboxyl-terminal Domain of Chemokine Receptor CCR5 That Regulate Signaling and Receptor Internalization
J. Biol. Chem.,
September 7, 2001;
276(37):
34408 - 34418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Bennett, T. D. Foutz, V. V. Gurevich, L. A. Sklar, and E. R. Prossnitz
Partial Phosphorylation of the N-Formyl Peptide Receptor Inhibits G Protein Association Independent of Arrestin Binding
J. Biol. Chem.,
December 21, 2001;
276(52):
49195 - 49203.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|